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INTRODUCTION
In practice, acute pancreatitis is a common disorder
which can be difficult to diagnose. Because of the
nonspecific signs and limitations of the currently avai-
lable laboratory tests, medical imaging plays an im-
portant role in diagnosing acute pancreatitis in dogs and
cats. Because delayed therapy can lead to a fatal out-
come, a rapid recognition of the disease is important.
This report is the second one in a series of three, which
gives a review of acute pancreatitis in dogs and cats.
This article will discuss the indications, as well as the
advantages and disadvantages of the various medical
imaging techniques and of pancreatic biopsies. In ad-
dition, the treatment options and prognosis will be re-
viewed.
MEDICAL IMAGING
Radiography 
Under normal circumstances, the pancreas is not vi-
sible on plain radiographs (Simpson and Lamb, 1995;
Bischoff, 2003). In dogs with acute pancreatitis, in crea-
sed opacity and loss of visceral detail can be seen in the
right cranial abdomen (‘ground glass’ appearance) as-
sociated with local peritonitis (Hess et al., 1998; Bi-
schoff, 2003; Ruaux, 2003) (Figures 1a and 1b). On
ventrodorsal projections, the inflamed pancreas can
cause a displacement of the pyloric antrum to the left,
the descending duodenum to the right and the trans-
verse colon caudally (Simpson and Lamb, 1995; Hess
et al., 1998; Bischoff, 2003; Ruaux, 2003; Mix and Jo-
nes, 2006). In some patients, the proximal duodenum
appears dilated and fixed (C-shaped), displaced late-
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ABSTRACT
Diagnosing acute pancreatitis in dogs and cats is difficult. Abdominal ultrasonography provides specific
information about the size, shape and homogeneity of the pancreas, but is very dependent on the experience
of the operator and the quality of the echography machine. Abdominal radiography is less useful, while
computed tomography is less practicable in veterinary patients because of the anesthesia risks, the need for
experienced operators, and the high cost. Furthermore, computed tomography has low diagnostic value in cats.
Biopsy of pancreatic tissue remains the gold standard. Treatment consists of fluid therapy and nutritional
support, combined with pain medication, anti-emetics and antibiotics. The prognosis in dogs and cats is
variable and largely depends on the clinical condition of the patient at admission. It is usually guarded,
especially in cats. 
SAMENVATTING
Het diagnosticeren van acute pancreatitis bij honden en katten is moeilijk. Abdominale echografie verschaft
specifieke informatie over de grootte, vorm en homogeniciteit van de pancreas maar is erg afhankelijk van de ervaring
van de uitvoerder en de kwaliteit van het echografietoestel. Radiografieën van het abdomen zijn minder nuttig, terwijl
computertomografie minder bruikbaar is bij diergeneeskundige patiënten omwille van het anesthesierisico, de nood
aan ervaren uitvoerders en de hoge kostprijs. Bovendien heeft computertomografie een lage diagnostische waarde
bij de kat. De biopsie van pancreasweefsel blijft de gouden standaard. De behandeling omvat vloeistoftherapie en
nutritionele ondersteuning in combinatie met pijnmedicatie, anti-emetica en antibiotica. De prognose bij de hond en
de kat is variabel en afhankelijk van de klinische toestand van de patiënt op het tijdstip dat hij aangeboden wordt,
maar ze is meestal gereserveerd, vooral bij katten. 
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rally and dorsally, with a widening of the pyloroduo-
denal angle (Bunch, 2003; Ruaux, 2003; Watson,
2004). A static gas pattern can be noted in the trans-
verse colon and the descending duodenum, the wall of
which can be thickened (Hess et al., 1998; Bischoff,
2003). Gastric distention suggesting gastric outlet ob-
struction is another possible abnormality (Bunch,
2003). Radiographs of the thorax can show pleural ef-
fusion (Bischoff, 2003) or pulmonary disease (edema
or pneumonia) (Hess et al., 1998).  
Unfortunately, in one study of fatal cases of canine
pancreatitis (Hess et al., 1998), these possible abdo-
minal radiographic signs compatible with acute pan-
creatitis were seen in only 24% of the patients, whereas
68% showed ultrasonographic abnormalities sugge-
stive of pancreatitis. Therefore, abdominal radiography
has a low sensitivity in diagnosing pancreatitis. In
spite of this disadvantage, radiography offers the as-
sessment of other abdominal organs for ruling out dif-
ferential diagnoses, such as intestinal foreign body.
Furthermore, radiography is a widely and easily avai-
lable technique, which remains relatively inexpensive.
Radiography can be used in conjunction with abdomi-
nal ultrasound (Watson, 2004; Mix and Jones, 2006). 
In cats with acute pancreatitis, the same radio -
graphic changes can be seen as in dogs (Gerhardt et
al., 2001; Ferreri et al., 2003). However, these signs
are often subtle and inconsistent (Hill and Van Winkle,
1993; Mansfield and Jones, 2001), and the most
reported features are reduced abdominal contrast (28-
50%), dilated bowel loops (24-42%) and pleural
effusion (20-29%) (Gerhardt et al., 2001; Saunders et
al., 2002; Ferreri et al., 2003). In cats, hepatomegaly
can be seen in cases of concurrent hepatic lipidosis
(Akol et al., 1993).
Abdominal ultrasonography 
One of the most reliable and increasingly used diag -
nostic tools for pancreatitis in dogs and cats is ultra-
sound (US) of the abdomen. US has the advantage of
being non-invasive, safe and relatively low in cost. In-
formation can be obtained immediately and the whole
abdomen can be evaluated at the same time. In addi-
tion, it is becoming more available for general practi-
tioners (Watson, 2004). It is however important to un-
derline that the diagnostic value of US is strongly
operator and machine dependent. Furthermore, the de-
gree of pancreatic inflammation and edema also plays
a role (Simpson and Lamb, 1995; Ruaux, 2003; Wat-
son, 2004; Mix and Jones, 2006). In contrast to radio-
graphy, ultrasonography gives more specific informa-
tion about the size, shape and homogeneity of the
pancreas (Simpson and Lamb, 1995; Bunch, 2003;
Watson, 2004). However, false negative results are
possible (Ruaux, 2003), while not all lesions can be
correlated with the clinical status of the patient (Mix
and Jones, 2006). Therefore, it cannot be used as an ex-
clusion diagnostic procedure. In cats, more work has
been published to evaluate the sensitivity of several US
abnormalities of the pancreas. In contrast, the availa-
ble information in dogs is limited and further investi-
gation is required.
Most typically, there is a focal area of pain when
the US probe is placed over the region of the pancreas.
Due to edema, pancreatic swelling and peri-pancreatic
fat necrosis, the inflamed pancreas is more easy to
localize than the normal pancreas (Watson, 2004).
Findings suggestive for acute pancreatitis in dogs
include a diffusely enlarged pancreas (more than 2 cm
in diameter) with hypoechoic parenchyma, hyper -
echoic surrounding mesentery and generalized or local
peritoneal effusion (Simpson and Lamb, 1995; Hess et
al., 1998; Ruaux, 2003; Mansfield, 2004; Watson,
2004; Mix and Jones, 2006) (Figure 2). Thickening of
Figure 1a. Loss of serosal detail in the right cranial ab-
domen (arrow) on a ventrodorsal radioraphic image of
a dog with acute pancreatitis.
Figure 1b. Lateral radiographic image of the abdomen of
the dog seen in figure 1a.
Vlaams Diergeneeskundig Tijdschrift, 2010, 79 101
the stomach or duodenal wall and dilated bile ducts
can be present (Simpson and Lamb, 1995; Bunch,
2003; Watson, 2004; Mix and Jones, 2006). In one
study, pancreatitis was found to be the most common
cause of corrugated small intestine (especially
involving the duodenum) in both dogs and cats (Moon
et al., 2003). Less frequently, dilatation of the pan -
creatic duct may be detected, which is considered
pathognomonic for pancreatitis in human patients, and
probably also in companion animals (Simpson and
Lamb, 1995; Watson, 2004).  
Ultrasonography is a very useful imaging technique
in diagnosing acute pancreatitis in cats, especially
when it is combined with other tests. However, as a
single test, its sensitivity is controversial: depending
on the author cited, the sensitivity lies between 11%
en 67% (Swift et al., 2000; Gerhardt et al., 2001;
Forman et al., 2004). In a study by Saunders et al.
(2002), ultrasonographic evidence of acute pancreatic
necrosis was only present in 7 of 20 cats. This rela -
tively low sensitivity (35%) might be attributable to
the inappropriate adaptation of the ultrasonographic
diagnostic criteria used in dogs to cats. Indeed, the
typical image of a hypoechoic pancreas with
hyperechoic mesentery often seen in dogs was only
present in 25 to 35% of the cats in this study and in a
study by Ferreri et al. (2003). However, an enlarged,
irregular or hypoechoic pancreas and hyperechoic
peripancreatic mesentery were found by Kimmel et al.
(2001) in respectively 64% and 43% of the cases
involving cats (Figure 3). Beyond this, more subtle and
non-pancreatic changes can be diagnostically impor -
tant as well. Additional ultrasonographic abnormalities
in cats include abdominal effusion (31-45%),
distention of the gallbladder and common bile duct
(17-24%) (Figure 4), and thrombosis of the pan -
creaticoduodenal vein (5%). A hyperechoic, enlarged
liver consistent with hepatic lipidosis was seen in 28-
45% of cats with acute pancreatitis (Akol et al., 1993;
Gerhardt et al., 2001; Kimmel et al., 2001; Saunders et
al., 2002; Ferreri et al.; 2003). Less frequent findings
included small hyperechoic kidneys, mesenteric
lymphadenopathy, intestinal abnormalities and small
gallbladder with inspissated bile (Saunders et al.,
2002). 
Advanced imaging
Computed tomography
In contrast to human medicine, where computed to-
mography (CT) is the preferred modality for the diag -
nosis and assessment of the severity of acute pancrea-
titis, this technique has limited usefulness in veterinary
patients with suspected pancreatitis (Ruaux, 2003; Mix
and Jones, 2006). The three main reasons for this are
the requirement of anesthesia to avoid movement arti-
facts, the need for operator experience and technical
skills, and the high cost (Ruaux, 2003; Mix and Jones,
2006). However, in large practices and teaching hos-
pitals, where availability and cost are less of an issue,
CT can develop into a useful diagnostic step.
In a study using CT as a diagnostic test for pan-
creatitis in dogs, 64% of the patients had pathologic
changes (Spillman et al., 2000). In two case reports in
dogs, pancreatic necrosis and associated vascular com-
plications such as splenic vein thrombosis and renal in-
farction were diagnosed by contrast enhanced CT (Jae -
ger et al., 2003). 
Figure 4. Ultrasonographic image: dilation of the com-
mon bile duct (arrow) in a cat with acute pancreatitis.
Figure 2. Ultrasonographic image: hypoechoic enlarged
pancreas (big arrow) lined by hyperechoic mesentery
(small arrow) in a dog with acute pancreatitis.
Figure 3. Ultrasonographic image: hypoechoic enlarged
pancreas (big arrow) with several, regularly outlined
hyperechoic spots (small arrow) in a cat with acute pan-
creatitis.
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In cats, CT has a low diagnostic value. In one study
by Gerhardt et al. (2001), visualization of the pancreas
remained difficult after intravenous administration of
contrast medium. In contrast to this finding, Forman
et al. (2004) were able to visualize the pancreas in 95%
of the cats (with and without pancreatitis) using
contrast-enhanced CT. The sensitivity is low: evidence
of pancreatitis was observed in only 2 out of 10 cats
with acute pancreatitis (Gerhardt et al., 2001). Further -
more, the measurement of pancreatic size is influenced
by the positioning of the patient, which can create
discrepancies in patient-to-patient measure ments
(Forman et al., 2004).
Magnetic resonance imaging
Several studies have been published concerning
magnetic resonance imaging (MRI) in diagnosing
neuro endocrine pancreatic tumors in dogs. To the
authors’ knowledge, no information is yet available
about the use of this imaging technique in small
animals with acute pancreatitis.
Based on the current knowledge, the authors sug-
gest that abdominal US is clearly superior to CT as a
first test in dogs, especially small dogs, and in cats sus-
pected of pancreatitis. However, when US is negative
and the patient can tolerate anesthesia, CT can be con-
sidered in medium and large breed dogs. 
PANCREATIC BIOPSY AND FINE NEEDLE ASPI-
RATION 
Biopsy of the pancreas is considered the most relia -
ble test for diagnosing acute pancreatitis in dogs and
cats and is often used in publications as the golden
standard for evaluating the accuracy (sensitivity,
specificity) of a diagnostic test (Watson, 2004; Mix
and Jones, 2006; Zoran, 2006, De Cock et al., 2007;
Watson, 2007b). In a study by Newman et al. (2004),
73 pancreata from dogs presented for post-mortem
examination were histologically evaluated: while only
5.5% of them showed gross lesions suggestive of
pancreatitis, 64.4% revealed microscopic evidence. So
the lack of gross lesions during exploratory celiotomy
does not exclude the presence of pancreatitis, and it is
this fact that makes clear the importance of pancreatic
biopsy. In the same study, acute pancreatitis was found
to be present in 48.9%, as defined by the presence of
neutrophils and pancreatic necrosis. De Cock et al.
(2007) found acute pancreatitis in 15.7% of 115 cats
presented for necropsy, irrespective of the cause of
death. Histologic lesions were characterized by
neutrophilic inflammation, surrounded by areas of
necrosis. 
Biopsy is a specific technique, but not very sensi-
tive (Mix and Jones, 2006; Mansfield, 2004; Zoran,
2006), because the pancreatic lesions can be localized
instead of diffuse. Newman et al. (2004) and De Cock
et al. (2007) concluded that pancreatic inflammation
occurs in discrete areas within the pancreas rather than
diffusely, which might suggest that multiple biopsies
are required. Because the lesions are randomly distri-
buted, there is no preferred site for biopsy samples un-
less gross lesions are present (Newman et al., 2004). 
Another limitation is that histologic evidence of
pancreatic inflammation is common, even in patients
not suspected of pancreatic disease. This forms a di-
lemma for determining the clinical relevance of in-
flammatory lesions on surgical biopsy (Newman et
al., 2004). Pancreatic biopsies can be obtained by la-
paroscopy or by celiotomy. The need for anesthesia is
an important disadvantage for both, because patients
suspected of pancreatitis are often poor anesthetic can-
didates. Recently, laparoscopy has been evaluated and
appears to be safe and useful for the evaluation of
pancreatic disease (Webb and Trott, 2008). In addition,
this technique is less invasive than celiotomy. How ever,
the latter technique allows a more complete exploration
of the abdomen (Mix and Jones, 2006). 
Ultrasound-guided fine-needle aspiration does not
require anesthesia and may reveal necrosis or inflam-
mation of the pancreas. Because the pancreas is diffi-
cult to visualize ultrasonographycally, the experience
of the operator plays an important role (Mix and Jones,
2006).
TREATMENT AND PROGNOSIS
Treatment and prognosis of acute pancreatitis in
dogs and cats are closely associated with the severity
of the disease (Watson, 2004). In general, the goals of
treatment include eliminating the underlying cause,
restoring fluid and electrolyte balance, decreasing pan-
creatic secretion, controlling vomiting, relieving pain,
providing nutritional support if necessary and, if pos-
sible, managing complications such as acute renal fai-
lure or diffuse intravascular coagulation (Bunch, 2003;
Zoran, 2006). Treatment is mainly supportive. As for
other diseases, the treatment options are not always ba-
sed on scientific evidence and studies, but rely rather
on experience in practice and experience in human
medicine. Unfortunately, evidence based on properly
designed prospective, randomized, placebo controlled
studies is currently almost nonexistent for the treatment
of pancreatitis in dogs and cats. However, every part of
the treatment can be explained by the pathologic
changes that take place in acute pancreatitis. Doses and
product names of frequently used medications can be
found in Table 1.
Fluid and nutritional therapy
Fluid therapy and nutritional support are the cor-
nerstones of treating dogs and cats with acute pan-
creatitis (Bunch, 2003). Fluids will provide mainte-
nance requirements, reverse dehydration, replace
ongoing losses, restore electrolyte imbalances and sup-
port adequate tissue perfusion to avoid ischemia
(Bunch, 2003; Watson, 2004). Traditionally, complete
pancreatic rest by starvation was recommended to
avoid enzyme secretion and prevent further autodige-
stion of the inflamed pancreas and peri-pancreatic tis-
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sues (Qin et al., 2002). However, now it is thought that
feeding small amounts of food or providing another
type of nutritional support is beneficial, because pa-
tients with protein-calorie malnutrition have a worse
prognosis (Mansfield, 2004; Watson, 2004). Indeed, the
uptake of nutrients prevents abnormal enterocyt meta-
bolism, gut atrophy and bacterial translocation (Wat-
son, 2004; Zoran, 2006). 
In dogs and cats that are alert and not dehydrated,
small amounts of water followed by small amounts of
a low-fat, high-carbohydrate diet can be presented at
least 24 hours after the last episode of vomiting
(Bunch, 2003; Watson, 2004). A diet low in fat (< 25g/
1000kcal) and with a moderate protein content
(generally greater than 18% or 60g/1000kcal) is the
best choice for dogs, because these two ingredients
will stimulate pancreatic enzyme secretion (Simpson,
2006). Cats can be offered highly digestible food,
which ideally should contain high carbohydrate and
low to moderate fat concentrations, except when
concurrent diabetes mellitus is present. Because such
a diet is often not commercially available, the essential
thing is to find a diet that is well tolerated by the
gastrointestinal tract (Zoran, 2006). Forced feeding
must be avoided (Zoran, 2007). Garbage or low-
protein, high-fat diets should be avoided to prevent
relapse (Simpson, 2006; Lem et al., 2008).   
Hospitalization and more aggressive therapy are
Table 1. Frequently used medication in patients with acute pancreatitis.
Classification Group Examples Product Dose
Analgetics Opioid Fentanyl Fentanyl®* 1-5 µg/kg IV q 20-30min; 
2-5 µg/kg/h CRI; 
bandage 4 µg/kg/h  
Opioid Butorphanol Dolorex®+ 0.1-0.5 mg/kg SC, IM or IV
Dissociative anesthetic Ketamine Anesketin® 3-5 µg/kg/min CRI
Anti-emetics Serotonine-inhibitor Ondansetron Zofran®* 0.5 mg/kg IV loading dose, 
followed by 0.5 mg/kg/h CRI for 6h
or 0.5-1 mg/kg PO q 12-24h
Phenotiazine Prochlorperazine Buccastem®*, 0.5-1 mg/kg PO q 8-12h
Prochlorperazine EG®* 0.1-0.5 mg/kg SC, IM or IV
Anti-emetic and Metoclopramide Primperan®* 0.2-0.5 mg/kg PO, SC or IM q 6-8h
prokinetic Metoclopramide EG®* 1-2 mg/kg IV over 24h as CRI
Neurokinin-1 Maropitant Cerenia®+ 2 mg/kg PO q 24h
receptor-antagonist 1 mg/kg SC q 24h
Anti-ulcer Histamine-2 blocker Ranitidine Zantac®* 2 mg/kg PO, IM or IV q 8-12h
medication
Gastric mucosal Sucralfate Ulcogant®*, 0.5 g PO q 6-8h (< 20kg)
protectant Antepsin®*, Carafate®* 1-2 g PO q 6-8h (> 20kg)
Cats: 0.25 g PO q 8-12h
Proton pump inhibitor Omeprazole Gastrogard®*, 0.5-1.5 mg/kg PO or IV q 24h
Mepradec®*, Zanprol®* Cats: 0.75-1 mg/kg PO q 24h
Omeprazole EG Maximum of 8 weeks
Antibiotics Lincosamide Clindamycine Antirobe®, Clindabuc® 5.5 mg/kg PO q 12h
11 mg/kg PO q 24h
Fluoroquinolone Enrofloxacin Baytril®° 2.5 mg/kg PO q 12h
5 mg/kg SC or IV q 24h
Sulphonamide/ Sulphonamide/ Tribrissen 80® 15 mg/kg PO q 12h
Trimethoprim Trimethoprim
Aminoglycosides Amikacin Amukin®* 5-10 mg/kg SC, IM or IV q 8h
10-15 mg/kg SC, IM or IV q 24h
Aminopenicillines Ampicillin Albipen-LA®, AMPI-kel® 10-20 mg/kg PO, SC, IM or IV
Aminopenicillines Amoxicillin Clavubactin®
associated with clavulanic acid Clavobay®
beta-lactamase inhibitor 12.5 mg/kg PO q 12h
Antibacterial Nitroimidazole Metronidazole Stomorgyl® 12.5 mg metronidazole
and antiprotozoal (with spiramycin) + 23.4 mg spiramycine/kg PO q 24h
medication
CRI: constant rate infusion
*: Not registered for dogs and cats
+: Not registered for cats
°: Not registered for intravenous use in dogs and cats
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needed in more severe cases (Williams, 2000). Patients
presented in shock need intravenous crystalloids at
shock rate (60-90 ml/kg/h), followed by or combined
with synthetic colloids at a rate of 10 to 20 ml/kg/day
(Simpson and Lamb, 1995; Watson, 2004). Regular
adjustment of fluid therapy is required (Bunch, 2003).
It is advised to monitor packed cell volume, total
protein concentration and kidney function on a daily
basis. Serum electrolytes should be checked daily as
long as the animal is vomiting and should be
supplemented if needed. Especially hypokalemia
should be tightly controlled, as it can delay recovery
due to gas tro intestinal atony and contribute to
mortality (Watson, 2004).  
A transfusion of fresh frozen plasma (FFP) (or
whole blood) can supply protease inhibitors and albu-
min, although there is no proof of these beneficial ef-
fects either in animals or in humans (Simpson and
Lamb, 1995; Holm et al., 2003; Mansfield, 2004; Wat-
son, 2004; Mansfield, 2007). Transfusion of plasma can
be combined with the administration of heparin to pre-
vent disseminated intravascular coagulation and to en-
sure pancreatic perfusion (Simpson and Lamb, 1995:
Bunch, 2003; Watson, 2004), but the benefit of this ap-
proach has not yet been proven (Bunch, 2003). In our
experience, FFP transfusions have always been tolera-
ted in dogs and cats with severe acute pancreatitis. 
If anorexia continues or if vomiting persists for 2 or
3 days despite anti-emetic treatment, other nutritional
support is warranted (Watson, 2004). This nutritional
support in an early stage of the disease is even more
important in cats than in dogs, because of the risk of
developing hepatic lipidosis (Mansfield and Jones,
2001; Bunch, 2003; Zoran, 2006; Watson, 2007a).
During the first days, partial peripheral parenteral
nutrition (PPN) can supply about 50% of the daily
energy requirements in dogs and cats and can prevent
further catabolism by supplying readily available
glycerol as an energy source (Watson, 2004; Wor -
tinger, 2006). On a long-term basis (> 5 days),
nutritional support can be delivered by total parenteral
nutrition (TPN) via a central venous catheter (Simpson
and Lamb, 1995; Watson, 2007a). Both forms require
working strictly aseptically, because the solutions are
ideal media for the growth of bacteria and septicemia
is a serious complication (Delaney et al., 2006). Other
complications include electrolyte and metabolic
disturbances (hyperglycemia, hyperlipidemia),
adynamic ileus, throm bo phlebitis and the refeeding
syndrome, a disorder involving electrolyte shifts
associated with glucose transport following the
reintroduction of food after prolonged anorexia (Qin
et al., 2002; Qin et al., 2003; Mansfield, 2004; De -
laney et al., 2006). Although fewer complications were
seen with PPN than with TPN, survival is probably
more related to the underlying disease than to the type
of nutritional support delivered (Chan et al., 2002).
Villous atrophy and increased intestinal permeability,
disadvantages associated with PPN and TPN, are less
of a problem with total enteral nutrition (TEN). A
study by Qin et al. (2002) proved that early intrajejunal
nutrition (EIN) via a jejunostomy tube improves the
integrity and function of the intestinal mucosa and
reduces bacterial and endotoxin translocation.
Furthermore, it is the most natural route for
administering nutrients and it reduces nosocomial
infection, multiple organ failure and length of
hospitalization (Qin et al., 2002; Qin et al., 2003;
Wortinger, 2006). TEN also moderates the acute phase
response and improves disease severity and clinical
outcome (Qin et al., 2002). While not evaluating
exclusively patients with pancreatitis, Chan et al.
(2002) documented that significantly more animals
receiving supplemental enteral nutrition survived
compared to those receiving PPN alone. This fact
could prove the benefits of enteral nutrition, although
animals that tolerate enteral nutrition could simply be
less ill. The complications of TEN include problems
associated with surgery, obstruction of the tube,
aspiration pneumonia, overfeeding and refeeding
syndrome (Delaney et al., 2006). It is important that
TEN be delivered into the distal jejunum, because the
enteral hormone secretion (such as cholecystokinin,
secretin and gastrin) that causes pancreatic stimulation
is mostly located more proximally in the gastro -
intestinal tract (gastric antrum, duodenum and
proximal jejunum). Indeed, two studies (Qin et al.,
2003; Qin et al., 2007) showed that early intrajejunal
nutrition (in the form of an elemental diet) does not
significantly increase pancreatic juice secretion or
enzyme-protein synthesis and release. Simpson (2006)
shares the opinion that enteral nutrition is superior to
parenteral nutrition, but questions whether jejunal
delivery of nutrients is necessary, because evidence
exists that pancreatic enzyme synthesis is down
regulated in dogs with acute pancreatitis. If this is
indeed the case, then the benefit of enteral nutrition
would be due rather to reductions in the systemic
inflammatory response and the translocation of enteric
bacteria than to the reduction of pancreatic stimulation
(Simpson, 2006). Furthermore, possible complications
of EIN include surrounding peritonitis, reduced
gastrointestinal motility, osmotic diarrhea and
vomiting, the risks of anesthesia and the difficulty of
placing a tube surgically (Mansfield, 2004; Watson,
2004; Wortinger, 2006; Zoran, 2006). A feasible
alternative is the laparoscopic-assisted placement of
jejunostomy feeding tubes. This technique allows
direct visualization of the abdominal contents and the
jejunostomy site. It requires smaller incisions and
results in decreased postoperative pain, while the
associated complications are mild and comparable to
those seen with surgical placement (Hewitt et al.,
2004). If vomiting is under control in anorectic
animals, parenteral nutrition or EIN can be replaced
by naso-esophageal, esophagostomy or gastrostomy
tube feeding, which can be used for, respectively,
short-, medium- or long-term nutritional support
(Watson, 2004). Naso-esophageal tubes are the easiest
to place and anes thesia is not required, in contrast to
the two other types (Delaney et al., 2006; Wortinger,
2006). 
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In conclusion, despite its possible disadvantages,
EIN should still be preferred over TPN, which must be
restricted to patients who do not tolerate enteral feeding
(Simpson, 2006; Zoran, 2006; Watson, 2007a). 
Analgetics and anti-inflammatory agents
The benefit of analgesia in pancreatitis cases should
not be underestimated, because most patients suffer
from abdominal pain. Pain relief can be achieved using
opioids, both partial and full agonists, which have  the
advantage of causing few changes in pancreatic ducts
or secretions (Simpson and Lamb, 1995; Bunch, 2003;
Mansfield, 2004; Watson, 2004). An exception to this
rule is morphine, which causes spasms of the pan-
creatic duct (Zoran, 2006) and increased bile duct pres-
sure (Mansfield, 2004). A worthy alternative that
should be considered is a constant rate infusion of a low
dose of ketamine (dissociative anesthetic), because of
its minimal effects on gastrointestinal motility (Watson,
2004). During exploratory celiotomy, intra-abdominal
bupivacaine or lidocaine (local anesthetics) can be
used (Mansfield, 2004).
Nonsteroidal anti-inflammatory drugs (NSAIDS)
are absolutely contra-indicated due to their significant
side effects: gastrointestinal ulceration and prolonged
bleeding times (Watson, 2004). Furthermore, they have
the potential to evoke renal failure in animals with hy-
potension and/or shock. Just like NSAIDS, corticoste-
roids increase the risk for gastroduodenal ulcers. Be-
cause there is no clinical evidence that corticosteroids
reduce pancreatic inflammation in small animals and
because they impair the removal of α macroglobu-
line-proteases complexes from the plasma by the reti-
culo-endothelial system, their use should be avoided
(Bunch, 2003; Watson, 2004; Watson, 2007b). The
only exception to this rule is their use in cats with
acute pancreatitis and concurrent inflammatory bowel
disease or lymphocytic/plasmacytic cholangiohepatitis
(Zoran, 2006). 
It has been suggested that supplementation with
pancreatic enzymes could help in relieving postprandial
pain, probably due to a negative feedback mechanism,
but evidence in animals is still missing (Mansfield,
2004; Watson, 2004; Watson, 2007b). 
Anti-emetics and anti-ulcer medication
Preventing oral intake is a first step in tempering
acute vomiting, but administering anti-emetics is often
necessary. Central-acting drugs, such as pheno -
thiazines (e.g. chlorpromazine, prochlor perazine) and
serotonine-inhibitors (e.g. ondansetron, dolastron), are
preferred in dogs and cats (Bunch, 2003; Watson,
2004; Zoran, 2006), although the first group can cause
sedation (Watson, 2004). Metoclopramide is an
antagonist of the dopamine (D2) receptors at the
chemoreceptor trigger zone. It owes its anti-emetic
action to the fact that it produces increased tonus of
the lower esophageal sphincter, accelerated emptying
of the stomach and increased activity of the upper
intestinal tract. This could cause extra pancreatic
stimulation, which can better be avoided (de la Puente-
Redondo et al., 2007; Mans field, 2007). However, in
patients with ileus and gastric hypomotility, which can
contribute to refrac tory vomiting, this prokinetic effect
can be bene ficial (Zoran, 2006). Maropitant has
recently been registered for dogs, in contrast to the
phenothiazines, serotonine-inhibitors and metoclo -
pramide, which all require off-label use. This highly
specific neurokinin-1 receptor-antagonist is a strong
anti-emetic that inhibits both central and peripheral
causes of vomiting. Compared with metoclopramide,
maropitant showed a higher efficacy in the treatment
of ongoing emesis caused by a wide range of
underlying clinical etiolo gies, including pancreatitis.
Therefore, the duration of anti-emetic treat ment was
also shorter with maropitant. It is well tolerated and
clinically safe, and once-daily administration is
appropriate (de la Puente-Redondo et al., 2007). 
Compromised gastric mucosal viability and gas -
trointestinal ulceration are side effects of pancreatitis.
If gastrointestinal ulceration or compromised gastric
mucosal viability are suspected or diagnosed, a therapy
with mucosal protectants (e.g. sucralfate) and hista-
mine-2 (H2) blockers (e.g. ranitidine, cimetidine)
should be started (Watson, 2004). Proton pump inhi-
bitors, such as omeprazole, are good acid inhibitors
(Watson, 2004). Omeprazole only requires once daily
administration, but is not registered for use in dogs or
cats (Ramsey, 2008).
Antibiotics
Since bacteria do not play a role in the pathogene-
sis of acute pancreatitis in dogs and cats, and septic
complications are rather rare, the benefit of routine an-
tibiotic therapy has been called into doubt (Mansfield,
2007). In opposition to this consideration, however,
necrotizing pancreatitis is known to be an ideal envi-
ronment for bacterial colonization, and antibiotic tre-
atment has indeed led to a better outcome in human pa-
tients and experimental canine cases (Watson, 2004;
Zoran, 2006). In most cases, and especially if patients
have fever or sepsis, parenteral broad-spectrum anti-
biotic treatment is started (Washabau, 2001; Bunch,
2003; Watson, 2004; Zoran, 2006). Holm et al. (2003)
restrict the use of antibiotics to patients with docu-
mented pancreatic infection and to protracted cases of
acute pancreatitis failing to respond to supportive the-
rapy. In human patients, pancreatic infections are most
commonly caused by Gram-negative enteric patho-
gens (Holm et al., 2003).
Antibiotics frequently used in patients with acute
pancreatitis include trimethoprim-sulphonamides
(TMS), aminoglycosides (e.g. amikacin) and
fluoroquinolones (e.g. enrofloxacin) (Bunch, 2003;
Watson, 2004). The fluoroquinolones penetrate well in
several tissues, including the pancreas, because they
are highly lipophilic drugs, while TMS is less effective
in the presence of necrotic tissue (Ramsey, 2008). All
previous types of antibiotics have a bactericidal effect
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against Gram-negative bacteria, while TMS and
fluoroquinolones are also effective against some
Gram-positive micro-organisms (Ramsey, 2008).
Since anaerobe bacteria are not sensitive to these types
of antibiotics, it is advisable to combine them with
lincosamides (e.g. clindamycine) or nitro-imidazoles
(e.g. metronidazole) (Holm et al., 2003; Mansfield,
2007). Another option is the use of ampicillin, which
is an aminopenicillin. Its spectrum includes many
Gram-positive and Gram-negative aerobic organisms
and obligate anaerobes, but it is inactivated by
organisms that produce beta-lactamases (Bunch, 2003;
Ramsey, 2008). To avoid this dis advantage,
aminopenicillin can be combined with a betalacta -
mase-inhibitor. Several products are registered for
companion animals and have few side effects.
Surgical treatment
Surgical intervention is warranted in cases of
pancreatitis that are persistent or recurrent despite
medical management to confirm the diagnosis and to
detect neo plasia or complicating factors such as an
infection (Simpson and Lamb, 1995; Simpson, 2006).
Other cases, such as permanent bile duct obstruction
and infected pancreatic necrosis, require surgical
intervention (Simpson and Lamb, 1995; Bunch, 2003).
If pancreatitis is localized to a focal area, this lobe can
be surgically removed. If surgery is performed,
cultures and biopsies are indicated (Williams, 2000).
In a recent study in human patients with acute
pancreatitis, peritoneal lavage helped in removing
cytokines and enzymes (Caronna et al., 2009). Since
there are no controlled clinical studies in dogs, this
technique, if used at all, should be used very cautiously
(Holm et al., 2003).
Prognosis
The prognosis of acute pancreatitis is variable be-
cause of the unpredictable nature and the wide spec-
trum of severity of the disease. Dogs with only one epi-
sode of mild pancreatitis usually have a good prognosis
(Bunch, 2003). In patients with severe pancreatitis,
the prognosis depends on the number of complications
(Bunch, 2003; Holm et al., 2003), but is mostly guar-
ded to poor (Watson, 2004). Increase in trypsinogen ac-
tivation peptide and certain abnormalities in the blood
analysis (such as hypoglycemia, azotemia, elevated d-
dimers) are considered worse prognostic indicators
(Simpson and Lamb, 1995). In contrast to humans,
the presence of necrosis alone cannot be used as an in-
dicator of poor prognosis, because it is rather the sys-
temic complications induced by the necrosis that cause
death (Mansfield et al., 2003). Several severity scoring
systems have been described in canine patients with
acute pancreatitis. One system, based on human crite-
ria, classified pancreatitis as severe if two or more of
the following parameters were present: necrosis of
pancreatic tissue, systemic complications, severe cli-
nical symptoms causing profound obtundation and de-
velopment of abdominal complications (Mansfield et
al., 2003). It is reliable, but has the disadvantage that
biopsy of pancreatic tissue to assess for necrosis is sel-
dom performed ante-mortem in companion animals.
Another approach is the use of a scheme based on cli-
nicopathologic abnormalities due to the compromise or
failure of extra-pancreatic organs. In 68 cases of spon-
taneous canine acute pancreatitis, this classification
correlated with outcome (Ruaux and Atwell, 1998).
However, the scoring system devised did not assess de-
finitively confirmed cases of pancreatitis and non-cli-
nicopathologic findings were not used. Recently, a cli-
nical severity index for dogs with acute pancreatitis has
been developed, based on abnormalities of the cardiac
and respiratory system, intestinal integrity and vascu-
lar forces (changes in albumin concentration and sys-
tolic arterial blood pressure). Intestinal health is of
especially great importance in dogs with acute pan-
creatitis, in particular during the period in which ente-
ral nutrition is lacking. This index showed a good cor-
relation between outcome and interval from hospital
admission until discharge or death. The overall morta-
lity rate among all dogs was 23%, while 53% of the
dogs with the worst clinical severity index score died
(Mansfield et al., 2008).
Because of the usually severe forms and the
difficult ante-mortem diagnosis, the prognosis in cats
is guarded (Bunch, 2003). Hypocalcemia (plasma
ionized calcium just below reference range), leuco -
penia, hypoalbuminemia, severe dehydration, ta chy-
 cardia, tachypnea and pyrexia are known as poor
prognostic signs (Hill and Van Winkle, 1993; Kimmel
et al., 2001; Bunch, 2003; Zoran, 2006).
CONCLUSION 
As the clinical signs and laboratory findings in
acute pancreatitis are non-specific, medical imaging is
usually needed to confirm the diagnosis and to assess
for concurrent diseases or complications. Currently,
abdominal ultrasonography is the preferred test, but it
requires an experienced sonographer. Further work
needs to be done to evaluate more advanced imaging
techniques such as MRI. Although pancreatic biopsy
and histologic evaluation are very sensitive tests if
multiple biopsies are taken, this is seldom used in
general practice because of the expense and the need
for anesthesia. Most patients need intensive therapy
and extensive monitoring to improve the chances for
survival and to prevent or address complications
rapidly. For the most severe cases, referral to an
intensive care facility needs to be considered. There is
an obvious need for well designed prospective studies
that evaluate the different aspects of the management
of pancreatitis. Hope fully, this will lead to a better
prognosis in the future.
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